8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 3, 2026·SEC
Material company update
Mar 16, 2026·SEC
KORU Medical Systems, Inc.(KRMD)Earnings, Financials & Key Ratios
KRMD•NASDAQ
$4.59
Price updated Jul 7, 2026
AboutKORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.Show more
- Revenue$41M+22.2%
- EBITDA-$2M+61.9%
- Net Income-$3M+56.5%
- EPS (Diluted)-0.06+56.1%
- Gross Margin60.28%-4.9%
- EBITDA Margin-5.26%+68.8%
- Operating Margin-7.23%+62.3%
- Net Margin-6.41%+64.4%
- ROE-15.58%+52.3%
KRMD Price & Volume
KORU Medical Systems, Inc. (KRMD) stock price & volume — 10-year historical chart
Loading chart...
Revenue Growth Struggles Against Persistent Operational Deficits
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Expanding
Profitability:Negative
Financial:Adequate
Cash Flow:Burning
Primary Risk:Persistent operating cash burn
Key Thesis Takeaways
- KORU Medical Systems demonstrates a robust top-line trajectory with 22.1% year-over-year revenue growth in 2026Q1, yet the company remains challenged by an inability to achieve operating leverage, evidenced by a -5.7% operating margin.
- While the firm maintains a conservative capital structure with a 0.20 debt-to-equity ratio, the persistent net losses and accumulated deficit of -$32.8M raise concerns regarding long-term financial sustainability.
- Investors should monitor whether the company can transition its expanding installed base of infusion drivers into consistent, positive free cash flow before the current $8.8M cash buffer is further eroded.
Verdict Logic
the company's inability to convert its 22.1% revenue growth into positive free cash flow, combined with a declining cash balance of $8.8M, suggests significant execution risk for long-term investors.
KRMD Growth Metrics
KORU Medical Systems, Inc. (KRMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.88%
5 Years11.21%
3 Years13.81%
TTM23.3%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM56.98%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM56.91%
Return on Capital
10 Years-10.37%
5 Years-25.61%
3 Years-26.24%
Last Year-14.85%
KRMD Recent Earnings
KORU Medical Systems, Inc. (KRMD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 7/12 qtrs (64%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.02+0.0%
$0.02
Rev
$12M+4.3%
$11M
Q2 2026
Mar 12, 2026Metric
Actual
Est
EPS
$0.01+50.0%
$0.02
Rev
$11M+0.7%
$11M
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.02+33.3%
$0.03
Rev
$10M-4.6%
$11M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.01+133.3%
$0.03
Rev
$10M+5.5%
$10M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.02vs $0.02+0.0% | $12Mvs $11M+4.3% |
| Q2 2026 | Mar 12, 2026 | $0.01vs $0.02+50.0% | $11Mvs $11M+0.7% |
| Q4 2025 | Nov 12, 2025 | $0.02vs $0.03+33.3% | $10Mvs $11M-4.6% |
| Q3 2025 | Aug 6, 2025 | $0.01vs $0.03+133.3% | $10Mvs $10M+5.5% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for KORU Medical Systems, Inc. (KRMD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $4.59 | $210.83M | -80.39 | 22.23% | -6.41% | -15.58% | — | |
| $32.80 | $1.66B | -136.67 | 14.88% | -0.83% | -0.95% | — | |
| $9.69 | $195.56M | 31.26 | 6.36% | 5.56% | 14% | — | |
| $105.70 | $2.41B | 41.94 | 13.53% | 24.35% | 16.19% | — | |
| $156.30 | $56.63B | 26.81 | 8.23% | 5.33% | 4.54% | — | |
| $22.86 | $11.8B | -13.06 | 5.72% | -9.7% | -16.5% | — |
Compare KRMD vs Peers
KORU Medical Systems, Inc. (KRMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
KRMD SEC Filings & Documents
KORU Medical Systems, Inc. (KRMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when KRMD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
KRMD Frequently Asked Questions
KORU Medical Systems, Inc. (KRMD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is KORU Medical Systems, Inc.'s revenue?
KORU Medical Systems, Inc. (KRMD) reported $43.3M in revenue for fiscal year 2025. This represents a 1994% increase from $2.1M in 1999.
How fast is KORU Medical Systems, Inc. growing?
KORU Medical Systems, Inc. (KRMD) grew revenue by 22.2% over the past year. This is strong growth.
Is KRMD profitable?
KORU Medical Systems, Inc. (KRMD) reported a net loss of $2.3M for fiscal year 2025.
Dividend & Returns
What is KRMD's return on equity?
KORU Medical Systems, Inc. (KRMD) has a return on equity (ROE) of -15.6%. Negative ROE indicates the company is unprofitable.
What is KORU Medical Systems, Inc.'s free cash flow?
KORU Medical Systems, Inc. (KRMD) generated $0.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.